| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
JP:4502
Takeda Pharmaceutical Co
|
Jul 07, 2026 | BUY |
Strong Buy
-1.3% avg upside
8 analysts
|
$6900.00
28.71% Upside
|
· |
|
JP:4503
Astellas Pharma
|
Jul 07, 2026 | HOLD |
Buy
+1.0% avg upside
6 analysts
|
$2200.00
2.73% Upside
|
· |
|
JP:4519
Chugai Pharmaceutical Co
|
Jul 07, 2026 | BUY |
Strong Buy
+32.1% avg upside
6 analysts
|
$9800.00
32.60% Upside
|
· |
|
JP:4568
Daiichi Sankyo Company
|
Jul 07, 2026 | BUY |
Strong Buy
+64.2% avg upside
7 analysts
|
$4500.00
64.89% Upside
|
· |
|
JP:4523
Eisai Co
|
Jan 16, 2026 | BUY |
Buy
+17.1% avg upside
6 analysts
|
$6100.00
41.91% Upside
|
· |
|
JP:4507
Shionogi & Co
|
Jan 16, 2026 | HOLD |
Buy
-3.9% avg upside
6 analysts
|
$2700.00
4.75% Downside
|
· |
|
JP:4578
Otsuka Holdings Co
|
Oct 10, 2025 | HOLD |
Strong Buy
-7.9% avg upside
7 analysts
|
$7800.00
30.25% Downside
|
· |
|
OTSKY
Otsuka Holdings Co
|
Apr 08, 2025 | HOLD |
Hold
1 analyst
|
— | +38.0% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.